Anlon Healthcare IPO Day 3: Issue Subscribed 7.12x, GMP at 5.49%
The bidding window for the Anlon Healthcare IPO will close today on August 29, 2025 and the allotment process is expected to be finalised on September 1, 2025. The shares of Anlon Healthcare Ltd will be listed on both the BSE and NSE websites with a tentative listing date fixed as September 3, 2025.
Anlon Healthcare Limited launched its Initial Public Offering (IPO) on August 26, 2025 with an issue size of ₹121.03 crores. The company specialises in the production of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs).
Anlon Healthcare IPO Day 3 Subscription Status
[August 29, 2025, 05:12 PM]
On Day 3, Anlon Healthcare IPO saw a subscription of 7.12 times, as per NSE data. The public issue was subscribed 47.29 times in the Retail Individual Investors (RIIs) category, 10.61 times in the Non-Institutional Investors (NII) category, and 1.07 times in the Qualified Institutional Buyers (QIBs) category.
Also Read: Anlon Healthcare IPO Day 1 Subscription Status, Anlon Healthcare IPO Day 2 Subscription Status
Anlon Healthcare IPO Details
Anlon Healthcare IPO is a book build issue of ₹121.03 crores. The issue is entirely a fresh issue of 1.33 crore shares.
The IPO price band is set at ₹86 - ₹91 per share. The lot size for an application is 164. The minimum investment required by a retail investor is ₹14,104 (164 shares).
Interactive Financial Services Ltd. is the book running lead manager, and Kfin Technologies Ltd. is the registrar of the issue.
Utilisation of Proceeds
The company will utilise the net proceeds from the issue towards the following purposes:
- Funding capital expenditure requirements for the Proposed Expansion.
- Full or part repayment and/or prepayment of certain outstanding secured borrowing (term loan) availed by the Company.
- Funding the working capital requirements of the Company.
- General corporate purposes.
Check out newly Listed IPOs on BSE and NSE.
Anlon Healthcare Limited GMP Details
According to NDTV Profit, the Grey Market Premium (GMP) of Anlon Healthcare Limited is ₹5 as of August 29, 2025, 08:56 a.m. This indicates that the estimated listing price can be ₹96 as per the upper price band, which is ₹91. The estimated gain per share is 5.49%.
|
Source: NDTV Profit Report dated August 29, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Anlon Healthcare Ltd - Business Overview
Anlon Healthcare Limited, incorporated in 2013 and based in Rajkot, is a chemical manufacturing company specialising in high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Its offerings include pharmaceutical formulations, nutraceuticals, personal care, and veterinary products. The company has 65 commercial products, with several more under pilot and lab stages.
Financially, the company reported a revenue of ₹120.46 crore in FY25, up from ₹66.69 crore in FY24, while Profit After Tax (PAT) increased to ₹20.52 crore. Total assets rose to ₹181.30 crore, reflecting expansion and improved operational efficiency.
Explore other Upcoming IPOs on BSE and NSE.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.